Loading...
XASXM7T
Market cap51mUSD
Jan 08, Last price  
0.35AUD
1D
0.00%
1Q
-36.11%
Jan 2017
-9.21%
IPO
-99.61%
Name

Mach7 Technologies Ltd

Chart & Performance

D1W1MN
XASX:M7T chart
P/E
—
P/S
2.86
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
11.07%
Rev. gr., 5y
25.52%
Revenues
29m
+43.77%
069,544855,0004,801,0002,132,62655,73515,766002,661,197143,8781,858,85510,268,9318,644,3459,347,14618,862,20119,027,09318,609,22520,258,15529,126,046
Net income
-8m
L+660.45%
0-1,522,816-1,538,000-4,229,000-3,160,205-3,781,2631,367,566-423,674-938,813-302,272-6,909,809-14,563,297-17,659,098-4,953,396-7,058,729169,293-9,357,196-4,167,850-1,048,112-7,970,324
CFO
3m
P
00000-577,153000-1,766,953-3,368,506-5,160,808-2,186,029-2,904,0424,748,4111,496,1836,373,929-2,612,0473,450,348
Earnings
Feb 26, 2025

Profile

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing solutions that include eUnity enterprise viewer, eUnity diagnostic viewer, and simplify image access. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation, training, support, and maintenance services, as well as project management. Mach7 Technologies Limited was incorporated in 1977 and is headquartered in South Burlington, Vermont.
URL
https://mach7t.com/
IPO date
Nov 30, 2005
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
29,126
43.77%
20,258
8.86%
18,609
-2.20%
Cost of revenue
51,439
46,562
41,907
Unusual Expense (Income)
NOPBT
(22,313)
(26,303)
(23,298)
NOPBT Margin
Operating Taxes
(1,785)
(5,608)
(2,167)
Tax Rate
NOPAT
(20,528)
(20,696)
(21,131)
Net income
(7,970)
660.45%
(1,048)
-74.85%
(4,168)
-55.46%
Dividends
Dividend yield
Proceeds from repurchase of equity
187
185
958
BB yield
-0.12%
-0.12%
-0.82%
Debt
Debt current
181
(2,446)
191
Long-term debt
2,355
2,192
2,462
Deferred revenue
(7,000)
(9,024)
Other long-term liabilities
9,024
Net debt
(28,189)
(28,655)
(23,095)
Cash flow
Cash from operating activities
3,450
(2,612)
6,374
CAPEX
(147)
(361)
(439)
Cash from investing activities
(391)
(361)
(439)
Cash from financing activities
(32)
(69)
548
FCF
(20,448)
(20,624)
(21,748)
Balance
Cash
26,175
23,395
25,748
Long term investments
4,550
5,006
Excess cash
29,269
27,388
24,817
Stockholders' equity
51,857
59,484
58,375
Invested Capital
23,856
33,297
34,884
ROIC
ROCE
EV
Common stock shares outstanding
240,895
239,386
237,725
Price
0.64
3.23%
0.62
26.53%
0.49
-53.99%
Market cap
154,173
3.88%
148,419
27.41%
116,485
-53.39%
EV
125,984
119,764
93,390
EBITDA
(15,062)
(25,131)
(21,988)
EV/EBITDA
Interest
62
51
55
Interest/NOPBT